160results about How to "Prevent and reduce occurrence" patented technology

A backlight device capable of preventing or reducing, even when an optical sheet bends, occurrence of luminance nonuniformity and / or shades due to the bend. The backlight device 1 controls the properties of light emitted by a light source 12 using two upper and lower diffusion sheets 16, 20 and a lens sheet 18 placed between the diffusion sheets and illuminates the back side of a display panel with the light, in which a space 24 for expansion is provided between the lens sheet 18 and the upper diffusion sheet 20, the space for expansion accommodating a bend of the lens sheet 18 which is caused by expansion due to heat from the light source 12.

A device and method of use for treating a medical disorder by surgically implanting into a patient at least one sensor element capable of detecting and conveying cell signals; attaching a management unit such that a micro controller of the management unit is connected to at least one sensor element; and connecting the management unit via a lead bundle to at least one treatment device. The treatment device may be an electrical stimulation device, a magnetic stimulation device, a heat transfer device, or a medication delivery device. Responsive to signals from the one or more sensor elements, mathematical algorithms of the management unit use wavelet crosscorrelation analysis to prompt delivery of at least one treatment modality, such heat transfer, current pulses, magnetic stimulation or medication. The medical disorder may arise from the brain, central nervous system or organs and tissues outside of the central nervous system.

An anti-wrinkle device is a light-weight, rigid, hollow member ergonomically contoured to fit comfortably in the area between the breasts of a human female. The hollow member is designed to prevent wrinkles from occurring in the cleavage area when women are lying on their shoulders and / or sides while sleeping. The member is covered with a soft, removable washable fabric. A sleeveless top can be worn to hold the member in place.

Aspects of the invention can provide a driving circuit of an electro-optical device that can reduce or prevent bad influences of a transverse electric field and a crosstalk. There can be provided a driving circuit of an electro-optical device, the driving circuit generating timing signals for supplying scanning signals to a display unit in which pixels can be formed corresponding to the respective intersections between a plurality of data lines and a plurality of scanning lines arranged in a matrix shape and the switching elements provided in the pixels are turned on by the scanning signals supplied to the scanning lines, so that the image signal supplied to the data lines are applied to the pixel electrodes of the pixels through the switching elements to drive the display unit. The driving circuit can include a transmission clock generating device for generating a transmission clock for sequentially transmitting the scanning signals to the scanning lines in synchronism with a signal having a frequency equal to a horizontal frequency of input image signals and outputting the transmission clock as a timing signal, a vertical reset signal generating device for generating a vertical reset signal synchronized with the transmission clock generated in close proximity of a vertical synchronizing signal of the input image signals, a scanning start pulse generating device for generating a scanning start pulse defining a start timing of a vertical scanning operation on the basis of the transmission clock and the vertical reset signal and outputting the scanning start pulse as a timing signal, and a writing image generating device for generating writing image signals to be supplied to the data lines by delaying the input image signals on the basis of the transmission clock and the vertical reset signal.

Immuno-adjuvant photodynamic therapy to treat and prevent metastatic cancer is effected using photosensitizers in combination with immuno-adjuvants to destroy metastatic tumor cells.

A prescription delivery computing system determines whether one or more prescriptions are respectively eligible to be delivered to the patient, the one or more prescriptions resultant from a telemedicine session conducted between a patient and a health care provider via a first patient computing device and a health care provider computing system; for the one or more prescriptions that are eligible to be delivered to the patient, obtains a price quote for delivery services to deliver the one or more prescriptions from a pharmacy to the patient, the price quote obtained from a delivery service computing system; provides the price quote for the delivery services to the patient for approval; responsive to receiving patient input data indicative of patient approval of the price quote for the delivery services, arranges for the delivery services to be performed; and transmits data that describes the one or more prescriptions to the pharmacy.

An interconnection structure includes an inter-level insulation layer disposed on a semiconductor substrate. First contact structures are formed in the inter-level insulation layer. Second contact structures are formed in the inter-level insulation layer and are spaced apart from the first contact structures. First spacers are disposed between the first contact structures and the inter-level insulation layer. Second spacers are disposed between the second contact structures and the inter-level insulation layer. Metal interconnections are disposed on the inter-level insulation layer and connected to the first and second contact structures. The first contact structures include first and second plugs stacked in sequence, the second contact structures include the second plugs, and the first spacers include an upper spacer disposed between the second plug and the inter-level insulation layer.

The present invention relates to methods of migraine prophylaxis using anti-CGRP receptor antibodies or binding fragments. In particular, methods for preventing or reducing the occurrence of migraine headache in a patient in need thereof comprising administering to the patient an anti-CGRP receptor or binding fragment according to specific dosage regimens are disclosed. Pharmaceutical compositions and administration devices comprising anti-CGRP receptor antibodies or binding fragments for use in the methods are also described.

Compositions comprising UV blocking agents, a film forming polymer containing acid groups and a neutralizing agent; compositions and methods for increasing the SPF of a composition by neutralizing at least a portion of the acid groups of the film forming agent with the neutralizing agent.

Methods and compositions containing huperzine are used to prevent and alleviate neuropathic pain. The invention is also directed to methods and compositions for using huperzine for the prevention and / or treatment of neuropathic pain and orthostatic hypotension.

Methods and compositions containing huperzine are used to alleviate pain and for the prevention and / or treatment of seizures and epilepsy. The invention is also directed to methods and compositions for using huperzine for the prevention and / or treatment of neuropathic pain and orthostatic hypotension.

Methylhydroxyethyl cellulose may be used as an additive in cement slurries in the treatment of wells to prevent or reduce the occurrence of gas channeling. In addition to acting as a gas control additive, methylhydroxyethyl cellulose controls fluid loss, minimizes free fluid and stabilizes foam during cementing of the well.